Cargando…

Corrigendum to “PLOD2 Is a Potent Prognostic Marker and Associates with Immune Infiltration in Cervical Cancer”

Detalles Bibliográficos
Autores principales:	Li, Guang, Liu, Guobing, Wang, Xuefeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Corrigendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8557080/ https://www.ncbi.nlm.nih.gov/pubmed/34725641 http://dx.doi.org/10.1155/2021/9762405

Ejemplares similares

PLOD2 Is a Potent Prognostic Marker and Associates with Immune Infiltration in Cervical Cancer
por: Li, Guang, et al.
Publicado: (2021)

Corrigendum to “The novel putative methyltransferase METTL7A as one prognostic biomarker potentially associated with immune infiltration in human renal cancer”
por: Yang, Zhiqian, et al.
Publicado: (2023)

PLOD3 Is Associated with Immune Cell Infiltration and Genomic Instability in Colon Adenocarcinoma
por: Deng, Xianyu, et al.
Publicado: (2021)

PLOD2 high expression associates with immune infiltration and facilitates cancer progression in osteosarcoma
por: Wang, Zhen, et al.
Publicado: (2022)

Corrigendum to “System Analysis of ROS-Related Genes in the Prognosis, Immune Infiltration, and Drug Sensitivity in Hepatocellular Carcinoma”
por: Xu, Jun Hui, et al.
Publicado: (2022)

PLOD2 Is a Prognostic Marker in Glioblastoma That Modulates the Immune Microenvironment and Tumor Progression
por: Kreße, Nina, et al.
Publicado: (2022)

PLK1 as a potential prognostic marker of gastric cancer through MEK-ER K pathway on PDTX models [Corrigendum]
Publicado: (2019)

PB1798: EVALUATION OF EXPRESSION OF PLODS FAMILY GENES (PLOD1, PLOD2, PLOD3) IN PATIENTS WITH ACUTE MYELOID LEUKEMIA
por: Zaker, F., et al.
Publicado: (2022)

Corrigendum to “Peritumoral EpCAM Is an Independent Prognostic Marker after Curative Resection of HBV-Related Hepatocellular Carcinoma”
por: Dai, Xiao-Meng, et al.
Publicado: (2017)

Corrigendum to Long Noncoding RNA PTTG3P Expression Is an Unfavorable Prognostic Marker for Patients With Hepatocellular Carcinoma
Publicado: (2020)

Vitamin D supplementation and immune-related markers: An update from nutrigenetic and nutrigenomic studies – CORRIGENDUM
por: Antony Dhanapal, Anto Cordelia Tanislaus, et al.
Publicado: (2023)

Sinonasal Symptoms in COPD: Burden and Associations with Clinical Markers of Disease [Corrigendum]
Publicado: (2022)

Corrigendum to “Role of Baicalin in Anti-Influenza Virus A as a Potent Inducer of IFN-Gamma”
por: Chu, Ming, et al.
Publicado: (2022)

Corrigendum to “Chaperone-Mediated Autophagy Markers LAMP2A and HSC70 Are Independent Adverse Prognostic Markers in Primary Resected Squamous Cell Carcinomas of the Lung”
por: Losmanová, Tereza, et al.
Publicado: (2021)

Corrigendum: Analysis of platelet parameters and activation markers in hematologic metastases of lung cancer
Publicado: (2019)

Corrigendum to “Claudin-1 Is a Valuable Prognostic Biomarker in Colorectal Cancer: A Meta-Analysis”
por: Zuo, Didi, et al.
Publicado: (2020)

Variations in the Wnt/β-Catenin Pathway Key Genes as Predictors of Cervical Cancer Susceptibility [Corrigendum]
Publicado: (2020)

Corrigendum to “Fatal Vertebral Artery Injury in Penetrating Cervical Spine Trauma”
por: Tannoury, Chadi, et al.
Publicado: (2017)

Corrigendum to “Prognostic Role of Neutrophil to Lymphocyte Ratio in Ovarian Cancer: A Meta-Analysis”
Publicado: (2020)

Corrigendum
por: Zong, Wubei, et al.
Publicado: (2023)

Continuous Wound Infiltration of Local Anesthetics in Postoperative Pain Management: Safety, Efficacy and Current Perspectives [Corrigendum]
Publicado: (2020)

Sam68 is a novel marker for aggressive neuroblastoma [Corrigendum]
Publicado: (2014)

Corrigendum to “ECG Markers of Hemodynamic Improvement in Patients with Pulmonary Hypertension”
por: Waligóra, Marcin, et al.
Publicado: (2018)

Corrigendum to “Evaluation of Plasma MicroRNAs as Diagnostic and Prognostic Biomarkers in Pancreatic Adenocarcinoma: miR-196a and miR-210 Could Be Negative and Positive Prognostic Markers, Respectively”
por: Yu, Qi, et al.
Publicado: (2018)

Prognostic significance of the infiltration of CD163(+) macrophages combined with CD66b(+) neutrophils in gastric cancer
Publicado: (2018)

Corrigendum to “Inhibition of Uncoupling Protein 2 Enhances the Radiosensitivity of Cervical Cancer Cells by Promoting the Production of Reactive Oxygen Species”
por: Liu, Cui Hua, et al.
Publicado: (2021)

Corrigendum to “Recurrent Syncope Associated with Lung Cancer”
por: Zhang, Dingguo, et al.
Publicado: (2016)

Corrigendum to “The Prognostic Significance of Tumor Deposit Count for Colorectal Cancer Patients after Radical Surgery”
por: Zheng, Kuo, et al.
Publicado: (2020)

Expression and Prognostic Role of PLOD1 in Malignant Glioma
por: Wang, Hao, et al.
Publicado: (2020)

PCOLCE Is Potent Prognostic Biomarker and Associates With Immune Infiltration in Gastric Cancer
por: Xiang, Aizhai, et al.
Publicado: (2020)

Corrigendum to ‘clinical and genetic landscape of treatment naive cervical cancer: Alterations in PIK3CA and in epigenetic modulators associated with sub-optimal outcome’
por: Scholl, Suzy, et al.
Publicado: (2020)

Corrigendum: IRB Approval Number Correction. Cardiac Dysfunction in Association with Increased Inflammatory Markers in Primary Aldosteronism
por: Lim, Jung Soo, et al.
Publicado: (2020)

Corrigendum: Bone Metabolic Markers in Patients with Obstructive Sleep Apnea Syndrome
Publicado: (2018)

Corrigendum to “Hematological Inflammatory Markers in Patients with Clinically Confirmed Familial Hypercholesterolemia”
por: Vaseghi, Golnaz, et al.
Publicado: (2023)

Circulating Serum Exosomal aHIF Is A Novel Prognostic Predictor For Epithelial Ovarian Cancer [Corrigendum]
Publicado: (2019)

Corrigendum to “High Apelin Level Indicates a Poor Prognostic Factor in Muscle-Invasive Bladder Cancer”
por: Yang, Long, et al.
Publicado: (2019)

Development and Validation of a Prognostic Classifier Based on Lipid Metabolism-Related Genes for Breast Cancer [Corrigendum]
Publicado: (2022)

Corrigendum to “Expression of HIF-2α and VEGF in Cervical Squamous Cell Carcinoma and Its Clinical Significance”
por: Zhang, Lixia, et al.
Publicado: (2017)

Securidaca–saponins are natural inhibitors of AKT, MCL-1, and BCL2L1 in cervical cancer cells [Corrigendum]
Publicado: (2019)

Indocyanine Green-Based Theranostic Nanoplatform for NIR Fluorescence Image-Guided Chemo/Photothermal Therapy of Cervical Cancer [Corrigendum]
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jcbb96907hd7ml3ajkveclgkap